<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02484963</url>
  </required_header>
  <id_info>
    <org_study_id>ILBS-Insomnia-001</org_study_id>
    <nct_id>NCT02484963</nct_id>
  </id_info>
  <brief_title>The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia</brief_title>
  <official_title>The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Liver and Biliary Sciences, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Liver and Biliary Sciences, India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      All Cirrhosis liver patients (Child A/B/C) presenting to Institute of Liver and Biliary
      Sciences will be screened for sleep disturbance and excessive daytime sleepiness with Epworth
      sleep score/ Pittsburgh sleep quality index. 52 patients of clinical/ radiological/ biopsy
      proven cirrhosis (Child A/B) will be enrolled after ruling out possibility of psychiatric
      illnesses like depression and anxiety with the help of PHQ-9 / GAD-7 questionnares. Patients
      who are suffering with sleep disturbance as evaluated with Pittsburgh sleep quality index
      will undergo polysomnography and will be randomised to two groups after fulfilling all
      inclusion criterias. Patients in group (Group 1) will receive zolpidem 5mg at bed time daily
      and patients in control group will receive placebo at bed time daily. The treatment will be
      continued for 4 weeks. After 4 weeks enrolled patients will be reassessed with PSQI and
      polysomnography. All patients will be advised regarding sleep hygiene.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2015</start_date>
  <completion_date type="Actual">January 15, 2017</completion_date>
  <primary_completion_date type="Actual">January 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in quality of sleep in CHILD A/B cirrhosis patients after 4 weeks as measured by total sleep time</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Precipitation of Hepatic encephalopathy with Zolpidem</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in daytime sleepiness with zolpidem as measured by ESS</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in sleep efficiency after treatment</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in periodic limb movements after treatment</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>zolpidem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tablet zolpidem 5mg once daily will be given for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One tablet of placebo will be given for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zolpidem</intervention_name>
    <arm_group_label>zolpidem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 70 years

          -  Clinical, Biochemical, Radiological ,Histological evidence of cirrhosis of all
             etiology

          -  Child A and B cirrhosis (for intervention part)

          -  Cirrhosis patients giving h/o persistent sleep disturbances (PSQIâ‰¥5)

          -  Child A, B and C cirrhosis (for observational part)

        Exclusion Criteria:

          -  Active alcohol intake or intake within 1 month of enrollment

          -  Active substance abuse or intake within 1 month of enrollment

          -  Known psychiatric and neurological disorders

          -  Patient using antidepressant, anticonvulsants, other hypnotics

          -  Pregnancy or lactation

          -  Overt hepatic encephalopathy (grade 2,3,4)

          -  Child C cirrhosis (for intervention part)

          -  Acute decompensated state of CLD (Chronic Liver Disease) - GastroIntestinal bleed,
             increased jaundice, HE (Hepatic Encepahlopahty) , SBP (Spontaneous Bacterial
             Peritonitis).

          -  HCC (HepatoCellular Carcinoma) with portal vein thrombosis

          -  Acute febrile illness/ acute infection

          -  Post TIPS (Transjugular Intrahepatic Portosystemic shunt)patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Liver and Biliary Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110070</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2015</study_first_submitted>
  <study_first_submitted_qc>June 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2015</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zolpidem</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

